« FDA collaboration to monitor rare eye condition associated with cataract | Main | FDA Approvals - Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL »

FDA Approvals - FDA approves Lannett's ANDA for Hydrochlorothiazide Capsules, 12.5 mgLannett Company,


FDA approves Lannett's ANDA for Hydrochlorothiazide Capsules, 12.5 mg
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
 

©2006 FDA-News.com. All rights reserved.